Align Technology, Inc. $ALGN Stock: Russell Investments Group Ltd. Grows Position

Russell Investments Group Ltd. grew its position in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 11.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 210,113 shares of the medical equipment provider’s stock after purchasing an additional 21,905 shares during the period. Russell Investments Group Ltd. owned approximately 0.29% of Align Technology worth $30,539,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. CENTRAL TRUST Co raised its holdings in Align Technology by 17,948.2% in the third quarter. CENTRAL TRUST Co now owns 44,218 shares of the medical equipment provider’s stock valued at $5,854,000 after buying an additional 43,973 shares during the period. New Mexico Educational Retirement Board grew its stake in Align Technology by 1,650.1% during the third quarter. New Mexico Educational Retirement Board now owns 58,630 shares of the medical equipment provider’s stock worth $7,801,000 after buying an additional 55,280 shares during the period. Maryland State Retirement & Pension System grew its stake in Align Technology by 1,959.0% during the third quarter. Maryland State Retirement & Pension System now owns 72,128 shares of the medical equipment provider’s stock worth $9,598,000 after buying an additional 68,625 shares during the period. Jefferies Financial Group Inc. increased its position in shares of Align Technology by 4.8% in the third quarter. Jefferies Financial Group Inc. now owns 47,530 shares of the medical equipment provider’s stock worth $6,674,000 after acquiring an additional 2,184 shares in the last quarter. Finally, Riverbridge Partners LLC increased its position in shares of Align Technology by 29.9% in the third quarter. Riverbridge Partners LLC now owns 53,950 shares of the medical equipment provider’s stock worth $7,543,000 after acquiring an additional 12,413 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ALGN. Mizuho cut their target price on shares of Align Technology from $220.00 to $200.00 and set an “outperform” rating on the stock in a research note on Thursday, October 22nd. Zacks Research cut shares of Align Technology from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Morgan Stanley decreased their price target on shares of Align Technology from $188.00 to $175.00 and set an “equal weight” rating for the company in a research report on Thursday, October 29th. Robert W. Baird downgraded Align Technology from an “outperform” rating to a “neutral” rating and lowered their price target for the company from $218.00 to $162.00 in a report on Thursday, October 15th. Finally, Wall Street Zen lowered Align Technology from a “buy” rating to a “hold” rating in a research report on Saturday, October 24th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $193.08.

Check Out Our Latest Research Report on Align Technology

Align Technology Stock Performance

Align Technology stock opened at $165.98 on Tuesday. The stock’s 50 day moving average price is $151.82 and its 200 day moving average price is $168.57. The firm has a market capitalization of $11.70 billion, a PE ratio of 24.16, a price-to-earnings-growth ratio of 2.16 and a beta of 1.74. Align Technology, Inc. has a one year low of $130.23 and a one year high of $200.43.

Align Technology (NASDAQ:ALGN – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.77 by $0.03. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. Align Technology’s revenue for the quarter was up 1.9% on a year-over-year basis. During the same quarter last year, the company earned $2.61 earnings per share. On average, analysts forecast that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.

Align Technology Profile

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Recommended Stories

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.